Table 4.
Comparison of clinical variables of Candida colonization vs controls
| Patients with Candida colonization, n=58 (%) | Patients without Candida, n=60 (%) | P | |
|---|---|---|---|
| Sex | |||
| Male | 41 (70.69) | 27 (45) | 0.005 |
| Female | 17 (29.31) | 33 (55) | |
| Age | |||
| Mean ± SD (years) | 66.12±14.17 | 50.60±15.56 | <0.001 |
| 0 – 14 | 0 | 0 | / |
| 15 – 49 | 5 (8.62) | 31 (51.67) | <0.0001 |
| 50 – 65 | 18 (31.03) | 19 (31.67) | 0.941 |
| >65 | 35 (60.34) | 10 (16.67) | <0.0001 |
| Hospital staya | |||
| Mean ± SD (days) | 29.55±32.90 | 16.95±13.17 | <0.001 |
| 0 – 7 days | 1 (1.72) | 12 (20) | 0.002 |
| 7 – 14 days | 14 (24.14) | 23 (38.33) | 0.097 |
| >14 days | 43 (74.14) | 25 (41.67) | <0.0001 |
| Clinical risk factors | |||
| Invasive interventions | |||
| Surgical procedures | 26 (44.83) | 12 (20) | 0.004 |
| Urethral catheters | 32 (55.17) | 17 (28.33) | 0.003 |
| Ventilatory support | 22 (37.93) | 13 (21.67) | 0.053 |
| Tracheal intubation | 29 (50) | 14 (23.33) | 0.003 |
| Arteriovenous cannulation | 30 (51.72) | 17 (28.33) | 0.009 |
| Tracheotomy | 8 (13.79) | 0 | 0.003 |
| PD or hemodialysis | 4 (6.90) | 5 (8.33) | 0.769 |
| Immune state | |||
| Immunosuppressive therapy | 3 (5.17) | 3 (5) | 0.495 |
| Comorbidities | |||
| Cancers | 27 (46.55) | 5 (8.33) | <0.0001 |
| Diabetes mellitus | 9 (15.52) | 7 (11.67) | 0.541 |
| Liver cirrhosis | 2 (3.45) | 0 | 0.147 |
| Concurrent Candida infections | 9 (15.52) | 0 | 0.001 |
| Coinfections of bacteria | 42 (72.41) | 28 (46.67) | 0.004 |
| Clinical outcomes | |||
| Improvement | 40 (68.97) | 54 (90) | 0.005 |
| Deterioration | 2 (3.45) | 6 (10) | 0.157 |
| Moribund | 1 (1.72) | 0 | 0.307 |
Notes: aTotal length of hospital stay for patients with invasive Candida infection or Candida colonization.
Abbreviation: PD, peritoneal dialysis.